Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Whitepaper

Increase Viable CHO Cell Density by Supplementation with Recombinant Insulin Human AF

By using the design of experiments approach in the production of chemically defined and non-animal-derived media, simultaneous testing of various compounds can help to determine potential interactions, as well as individual efforts.

Mammalian cells are one of the most widely used platforms in the production of biopharmaceuticals. Among them, Chinese hamster ovary (CHO) and human embryonic kidney (HEK 293) cells are extensively used for the production of recombinant proteins, vaccines and viral vectors.

Download this free white paper to find out more.

Increase Viable CHO Cell Density by Supplementation with Recombinant Insulin Human AF

For Free, instant access, click below.

Download Whitepaper

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.




Thank You

Your white paper is now downloading... Click here if the download does not begin.

Go Top